Nabriva Therapeutics plc
NBRV
Rangering i aksjer
#39901
Nabriva Therapeutics plc is a biopharmaceutical company focused on the... Nabriva Therapeutics plc is a biopharmaceutical company focused on the discovery and commercialization of innovative anti-infective medications to combat serious infections. The company's current marketed products include SIVEXTRO, an oxazolidinone-class antibacterial designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI), and XENLETA, a semi-synthetic pleuromutilin antibiotic utilized in managing community-acquired bacterial pneumonia. Beyond its existing offerings, Nabriva is further exploring XENLETA's potential in Phase I clinical trials for a broad spectrum of indications, such as pediatric infections, sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated and hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. Additionally, the firm is developing CONTEPO, an epoxide antibiotic for complicated urinary tract infections, which is also undergoing Phase I clinical evaluation for peri-operative prophylaxis. Originally incorporated in 2005 as Nabriva Therapeutics Forschungs GmbH, the company rebranded to Nabriva Therapeutics plc in 2007 and maintains its corporate headquarters in Dublin, Ireland.
Aksjekurs
$0.63
Sist synkronisert: 2023-08-29
Markedsverdi
$284.20K
Endring (1 dag)
-21.25%
Endring (1 år)
629,900.02%
Land
IE
Handel Nabriva Therapeutics plc (NBRV)
Kategori
Healthcare
Markedsverdi av Nabriva Therapeutics plc(NBRV)
Markedsverdi: $284.20K
Per October 2026 har Nabriva Therapeutics plc en markedsverdi på $284.20K. Dette gjør Nabriva Therapeutics plc til det 39901st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Nabriva Therapeutics plc fra 2023 til 2026
NBRV sammenlignet med topp 5 mest populære stocks
| Pris på NBRV | Eiendel B | Markedsverdi for B | Resultater | |
|---|---|---|---|---|
$1,599,703
$323.00
|
$5.167T | +1,599,702,786,277.71% | ||
|
$1,552,563
$323.00
|
$5.015T | +1,552,563,207,547.06% | ||
|
$1,271,951
$323.00
|
$4.108T | +1,271,951,153,813.31% | ||
|
$1,208,020
$323.00
|
$3.902T | +1,208,019,739,373.68% | ||
|
$832,649
$323.00
|
$2.689T | +832,648,929,311.77% |
